Immunotheraphy for the Treatment of Breast Cancer
Publication Date: March 15, 2024
Last Updated: May 31, 2024
Immunotherapy With PD-(L)1 Inhibitors for the Treatment of Advanced/Metastatic Breast Cancer
Clinical trial enrollment remains a priority to further understand the benefit of checkpoint inhibition in metastatic breast cancer.
()1317519
Emerging Data on Immunotherapy With PD-(L)1 Inhibitors for Early-Stage/Locally Advanced Breast Cancer
For all patients with stage II and III TNBC, clinical trial enrollment should be considered if available.
()1317519
Title
Immunotheraphy for the Treatment of Breast Cancer
Authoring Organization
Society for Immunotherapy of Cancer